The Study of Polycystic Ovary Syndrome(PCOS) With Gene and Questionnaire
NCT ID: NCT01114659
Last Updated: 2014-01-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
169 participants
OBSERVATIONAL
2009-11-30
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study of Polycystic Ovary Syndrome (PCOS) and Questionnaire
NCT01256970
Study of Metabolism and Cardiovascular Disease(CVD) in Women With Polycystic Ovary Syndrome (PCOS)
NCT01117558
To Study Polycystic Ovary Syndrome in Taiwanese Women
NCT01256944
Expression of CVD and HA Between Obesity and Non-obesity Polycystic Ovary Syndrome (PCOS) Women in Taiwan
NCT01113918
Clinical and Biochemical Presentation of Polycystic Ovary Syndrome in Different Age Group
NCT01350895
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with PCOS
No interventions assigned to this group
Normal Control
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* women with PCOS and women without PCOS.
Exclusion Criteria
* women older than 45 years old, Amenorrhea of menopause, hyperglycemia, hyperthyroidism, hypothyroidism, heart failure, lung failure, renal failure, anemia, dystrophy, gonitis.
15 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University WanFang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ming-I Hsu, MD
Attending Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ming-I Hsu, MD
Role: PRINCIPAL_INVESTIGATOR
Wan Fang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University WanFang Hospital
Taipei, Taipei, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WFH-PCOS-98076
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.